Nippon India Pharma Fund vs Aditya Birla Sun Life Pharma and Healthcare Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth
Chart Comparison
Overview
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹8346 Cr | ₹847 Cr |
| Min Investment | ₹5000 | ₹1000 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 05 Jun 2004 | 10 Jul 2019 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | BSE Healthcare |
| Turn Over | 21% | 31% |
| Expense Ratio | 1.82 | 2.27 |
| Manager | Sailesh Raj Bhan | Dhaval Joshi |
| ISIN Code | INF204K01968 | INF209KB1N91 |
| Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| 1 Month | -0.42% | -1.09% |
| 6 Month | 1.31% | 3.03% |
| 1 Year | -0.53% | -0.55% |
| 3 Year | 20.97% | 20.2% |
| 5 Year | 16.1% | 14.32% |
SIP Return Analysis
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| 6 Month | 0.75% | 0.03% |
| 1 Year | 6.3% | 5.05% |
| 3 Year | 16.99% | 16.35% |
| 5 Year | 16.43% | 15.37% |
Rolling Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| 1 Year | 16.7% | 22.08% |
| 3 Year | 20.91% | 17.2% |
| 5 Year | 20.41% | 20% |
Risk Management
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Standard Deviation | 15.23% | 16.02% |
| Sharp | 0.92% | 0.85% |
| Beta | 0.91% | 0.96% |
| Alpha | -0.55% | -1.71% |
Fund Managers
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Name | Sailesh Raj Bhan | Dhaval Joshi |
| Total AUM | ₹96086 Cr | ₹361932 Cr |
| Funds Managed | 5 | 55 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
Market Cap
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Others | 0.33 | 4.8 |
| Large Cap | 49.27 | 26.05 |
| Mid Cap | 20.35 | 39.79 |
| Small Cap | 30.05 | 29.36 |
Sector Allocation
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Others | 0.33 | 3.26 |
| Healthcare Services | 21.28 | - |
| Pharmaceuticals & Biotechnology | 75.07 | - |
| Retailing | 3.32 | - |
| Healthcare | - | 95.82 |
| Basic Materials | - | 0.92 |
Top Comparisons
Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth
3Y Returns35.52%
Axis NASDAQ 100 Fund of Fund - Regular Plan - Growth
3Y Returns32.25%
SBI Contra Fund Regular Plan Growth
3Y Returns18.98%
Invesco India Contra Fund - Growth
3Y Returns18.71%
Nippon India Short Duration Fund-Growth Plan
3Y Returns7.66%
Mirae Asset Short Duration Fund- Regular Plan -Growth
3Y Returns7.18%
HSBC Large & Mid Cap Fund - Regular Growth
3Y Returns18.9%
DSP Large & Mid Cap Fund - Regular Growth
3Y Returns19.24%